Juvenile and adult onset systemic lupus erythematosus outcome in Egyptian patients

Egyptian Rheumatologist

Volumn 33, Issue 2, 2011, Pages 99-105

  Gheita, Tamer A ^a   Fawzy, Samar M ^a   Nour El din, Abeer M ^b   El Fishawy, Hussein S ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Egyptians; Gender; Onset; Outcome; SLE

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CAUSE OF DEATH; CLINICAL FEATURE; DELAYED PUBERTY; DISEASE ACTIVITY; EGYPT; FEMALE; FIBROMYALGIA; GROWTH DISORDER; HUMAN; JUVENILE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84874915819     PISSN: 11101164     EISSN: 20902433     Source Type: Journal    
DOI: 10.1016/j.ejr.2011.03.006     Document Type: Article

References (48)

1. Papadimitraki E.D., Isenberg D.A. Childhood- and adult-onset lupus: an update of similarities and differences. Expert Rev Clin Immunol 2009, 5:391-403.
2. Kamphuis S., Silverman E.D. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol 2010, 6:538-546.
3. Lam G.K., Petri M. Assessment of systemic lupus erythematosus. Clin Exp Rheumatol 2005, 23(5 Suppl. 39):S120-A132.
4. Tikly M., Navarra S.V. Lupus in the developing world-is it any different?. Best Pract Res Clin Rheumatol 2008, 22:643-655.
5. Urowitz M.B., Gladman D.D., Tom B.D., Ibañez D., Farewell V.T. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 2008, 35:2152-2158.
6. Stichweh D., Arce E., Pascual V. Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 2004, 16:577-587.
7. Brunner H.I., Bishnoi A., Barron A.C., et al. Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus. Lupus 2006, 15:198-206.
8. Sallmann S., Fiebig B., Hedrich C.M., Heubner G., Gahr M. Systemic lupus erythematosus in children and adolescents. Z Rheumatol 2006, 65:576-578.
9. Ravelli A., Ruperto N., Martini A. Outcome in juvenile onset systemic lupus erythematosus. Curr Opin Rheumatol 2005, 17:568-573.
10. Gilboe I.M., Kvien T.K., Husby G. Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years. J Rheumatol 2001, 28:266-274.
11. Strand V., Gladman D., Isenberg D., Petri M., Smolen J., Tugwell P. End points: consensus recommendation from OMERCAT IV. Lupus 2000, 9:322-327.
12. Mayor A.M., Vilá L.M. Gender differences in a cohort of Puerto Ricans with systemic lupus erythematosus. Cell Mol Biol (Noisy-le-grand) 2003, 49:1339-1344.
13. El-Garf A., Salah S. Juvenile systemic lupus erythematosus among Egyptian children. J Rheumatol 1990, 17(9):1168-1170.
14. Salah S., Lotfy H.M., Sabry S.M., El Hamshary A., Taher H. Systemic lupus erythematosus in Egyptian children. Rheumatol Int 2009, 29(12):1463-1468.
15. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997, 40:1725.
16. Bombardier C., Gladman D., Urowitz M., Caron D., Chang C. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992, 35:630-640.
17. Gladman D., Ginzler E., Goldsmith C., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996, 39:363-369.
18. Gutiérrez-Suárez R., Ruperto N., Gastaldi R., et al. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum 2006, 54(9):2989-2996.
19. Churg J., Sobin D.H. Renal disease: classification and atlas of glomerular diseases 1982, Igaku-Shoin, Tokyo, p. 127-49.
20. Vitali C., Bombardieri S., Jonsson R., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
21. Wolfe F., Smythe H.A., Yunus M.B., et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33(2):160-172.
22. Brunner H.I., Gladman D.D., Ibañez D., Urowitz M.D., Silverman E.D. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008, 58:556-562.
23. Descloux E., Durieu I., Cochat P., et al. Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus. Rheumatology (Oxford) 2009, 48:779-784.
24. Al-Mayouf S.M., Al-Sonbul A. Influence of gender and age of onset on the outcome in children with systemic lupus erythematosus. Clin Rheumatol 2008, 27:1159-1162.
25. Yee C.S., Hussein H., Skan J., Bowman S., Situnayake D., Gordon C. Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology (Oxford) 2003, 42:276-279.
26. Mok C.C., Lee K.W., Ho C.T.K., Lau C.S., Wong R.W.S. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology 2000, 39:399-406.
27. Mok C.C., Ho C.T., Wong R.W., Lau C.S. Damage accrual in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2003, 30:1513-1519.
28. Voulgari P.V., Katsimbri P., Alamanos Y., Drosos A.A. Gender and age differences in systemic lupus erythematosus. A study of 489 Greek patients with a review of the literature. Lupus 2002, 11:722-729.
29. Gladman D.D., Urowitz M.B., Ong A., Gough J., MacKinnon A. Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life. Clin Exp Rheumatol 1996, 14:305-308.
30. Lo J.T., Tsai M.J., Wang L.H., et al. Sex differences in pediatric systemic lupus erythematosus: a retrospective analysis of 135 cases. J Microbiol Immunol Infect 1999, 32:173-178.
31. Hiraki L.T., Benseler S.M., Tyrrell P.N., Hebert D., Harvey E Silverman E.D. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr 2008, 152:550-556.
32. Ravelli A., Duarte-Salazar C., Buratti S., et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 2003, 15(49):501-507.
33. Freire E.A., Maia I.O., Nepomuceno J.C., Ciconelli R.M. Damage index assessment and quality of life in systemic lupus erythematosus patients (with long-term disease) in Northeastern Brazil. Clin Rheumatol 2007, 26:423-428.
34. Lilleby V., Flatø B., Førre O. Disease duration, hypertension and medication requirements are associated with organ damage in childhood-onset systemic lupus erythematosus. Clin Exp Rheumatol 2005, 23:261-269.
35. Vilar M.J., Bezerra E.L., Sato E.I. Skin is the most frequently damaged system in recent-onset systemic lupus erythematosus in a tropical region. Clin Rheumatol 2005, 24:377-380.
36. Rahman P., Gladman D.D., Urowitz M.B., Hallett D., Tam L.S. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus 2001, 10:93-96.
37. Benseler S.M., Bargman J.M., Feldman B.M., et al. Acute renal failure in paediatric systemic lupus erythematosus: treatment and outcome. Rheumatology (Oxford) 2009, 48:176-182.
38. Tucker L.B., Menon S., Schaller J.G., Isenberg D.A. Adult and childhood-onset systemic lupus erythematosus. A comparison of onset, clinical features, serology and outcome. Br J Rheumatol 1995, 34:866-872.
39. Lilleby V., Aaløkken T.M., Johansen B., Førre Ø Pulmonary involvement in patients with childhood-onset systemic lupus erythematosus. Clin Exp Rheumatol 2006, 24:203-208.
40. Bandeira M., Buratti S., Bartoli M., et al. Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus. Lupus 2006, 15:515-520.
41. Mahmoud S.S., Bazaraa H.M., Lotfy H.M., Abd-El-Aziz D.M. Renal involvement in childhood-onset systemic lupus erythematosus in Egypt. Rheumatol Int 2010, [Epub ahead of print]. 10.1007/s00296-010-1554-7.
42. Winfield JB. Fibromyalgia and SLE. In: Lahita RG, editor. Systemic lupus erythematosus, 4th ed.; 2004. p. 745-50.
43. Buskila D., Press J., Abu-Shakra M. Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications. Clin Rev Immunol 2003, 25:25-28.
44. Baer A.N., Maynard J.W., Shaikh F., Magder L.S., Petri M. Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset. J Rheumatol 2010, 37:1143-1149.
45. Hoffman RW. Overlap syndromes. In: Lahita RG, editor. Systemic lupus erythematosus, 4th ed.; 2004. p. 736.
46. Ramírez Gómez L.A., Uribe Uribe O., Osio Uribe O., et al. Childhood systemic lupus erythematosus in Latin America. Lupus 2008, 17:596-604.
47. Brunner H.I., Silverman E.D., To T., Bombardier C., Feldman B. Risk factors for damage in childhood onset SLE. Arthritis Rheum 2002, 46:436-444.
48. Garcia M.A., Marcos J.C., Marcos A.I., et al. Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus 2005, 14:938-946.